PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results : Reversible airways obstruction (Salbutamol - Asthma)
Records returned : 11 (on 23 Dec 2024 at 09:21:09). Return to search results for ' Reversible airways obstruction '.
Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
03.01.01
07.01.03
Green
Formulations :
- Nebules
ASPH
RSFT
SASH
SABP
Primary Care
Red
Formulations :
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
Important
Unlicensed use in under 12 years of age.
Non Formulary
Formulations :
- Modified release tablets
- Oral solution
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
03.03.02
Green
Formulations :
- Chewable tablets
- Sachets (granules)
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
https://www.gov.uk/drug-safety-update/montelukast-singulair-reminder-of-the-risk-of-neuropsychiatric-reactions
01.05.02
03.02.00
05.03.06
06.03.02
Blue
Formulations :
- Nebules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Asthma prophylaxis. Primary Care may prescribe on recommendation from the Respiratory Care Team who will ensure that patients have had suitable training and trial of equipment to ensure safe use.
03.01.01
Blue
Formulations :
- Nebules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Primary Care may prescribe on recommendation from the Respiratory Care Team who will ensure that patients have had suitable training and trial of equipment to ensure safe use.
Red
Formulations :
- Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Important
Specialised commissioned services only.
03.01.01
Red
Formulations :
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
Important
Severe acute asthma
N/A
Formulations :
- Inhaler (dry powder)
ASPH
RSFT
SASH
SABP
Primary Care
N/A
Formulations :
- Inhaler (dry powder)
ASPH
RSFT
SASH
SABP
Primary Care
03.01.03
See narrative
Formulations :
- Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Place in therapy under review. Therapeutic drug monitoring required. Not recommended for primary care initiation without specialist advice.
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients